Acura Pharmaceuticals, Inc. (ACUR)
| Market Cap | 9.39M |
| Revenue (ttm) | 3.57M |
| Net Income (ttm) | -1.21M |
| Shares Out | 32.32M |
| EPS (ttm) | -0.04 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 10 |
| Last Price | $0.3800 |
| Previous Close | $0.3800 |
| Change ($) | 0.0000 |
| Change (%) | 0.00% |
| Day's Open | 0.4000 |
| Day's Range | 0.3610 - 0.4250 |
| Day's Volume | 14,006 |
| 52-Week Range | 0.1500 - 0.4500 |
News
There are no news available yet.
About ACUR
Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six add... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | Founded 1935 |
| CEO Robert Jones | Employees 12 |
| Stock Exchange OTCMKTS | Ticker Symbol ACUR |
Financial Performance
In 2020, ACUR's revenue was $3.57 million, an increase of 34.36% compared to the previous year's $2.66 million. Losses were -$1.21 million, -67.99% less than in 2019.